Roswell Park Study Shows Venetoclax Enhances CAR T Immune Response for CLL
Research out of Roswell Park Comprehensive Cancer Center has shed light on how the drug venetoclax (brand name Venclexta) works synergistically with CAR T-cell immunotherapy to combat chronic lymphocytic leukemia (CLL),...
